Christine Cassiano | Chief Communications Officer |
David Chang | President and Chief Executive Officer |
Rafael Amado | Executive Vice President-Research and Development and Chief Medical Officer |
Eric Schmidt | Chief Financial Officer |
Tyler Van Buren | Cowen |
Salveen Richter | Goldman Sachs |
Michael Yee | Jefferies |
Kelsey Goodwin | Guggenheim |
Ren Benjamin | JMP Securities |
Jason Gerberry | Bank of America |
Mark Breidenbach | Oppenheimer |
David Dai | SMBC |
John Newman | Canaccord |
Luca Issi | RBC Capital |
Raju Prasad | William Blair |
Asthika Goonewardene | Truist Securities |
Kalpit Patel | B. Riley Securities |
Jack Allen | Baird |
Hello, thank you for standing by. And welcome to Allogene Therapeutics Second Quarter of 2022 Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer session. [Operator Instructions] Please be aware that today's conference call is being recorded.